Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
Bharat Biotech on Friday said it had terminated a memorandum of understanding to sell its Covid vaccine Covaxin to Brazil's Precisa Medicamentos.
advertisement
UPDATED: July 24, 2021 10:37 IST
Bharat Biotech on Friday said it terminated the Memorandum of Understanding with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its Covid-19 vaccine Covaxin. (Reuters photo)
Brazil has suspended the clinical studies of Bharat Biotech's Covid-19 vaccine Covaxin after termination of the company's agreement with its partner, as per reports.